Proactive Investors: Regeneus enters strategic collaboration

Wednesday, 28 December 2016

View the original story at Proactive Investors.

Regeneus (ASX:RGS) has been granted a trading halt by the ASX this morning, with its shares placed in pre-open.

Regeneus requested the halt pending details on the signing of transaction documents and information relating to the entry into a strategic collaboration and licensing agreement for Progenza stem cell technology in Japan.

The halt will remain in place until the opening of trade on Friday 30th December 2016, or earlier if an announcement is made to the market.